Labelled Rosuvastatin, a selective, competitive HMG-CoA reductase inhibitor. Synonyms: 7-[4-(4-Fluorophenyl)-6-(1-methylethyl-d6)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt Molecular Formula: C22H21D6FN3NaO6S Molecular Weight: 509.56 Purity: Chemical purity: ~95%, Isotopic purity: ~99% Appearance: White solid Solubility: Methanol (Slightly), Water (Slightly) Melting Point: >193C (dec.) Method for Determining Identity: Proton NMR (D2O) Spectroscopic analysis and Mass Spectrometric analysis TLC Conditions: C18, Methanol: Water=1:1, Visualized with UV and AMCS, Single spot, Rf=0.30 Elemenatl Analysis: %Calcuated: %C: 51.86, %H: 5.34, %N: 8.25 Normalized Intensity: d0: 0.31%, d1: 0.21%, d2: 0.08%, d3: 0.09%, d4: 0.34%, d5: 1.05%, d6: 97.91% Specifc Rotation: +18.9 (c=0.2, 50% Methanol in Water) Atmosphere: Inert Gas Storage and Stability: May be stored at RT for short-term only. Long-term storage is recommended at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Hygroscopic. Store under inert atmosphere. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.
Molekulargewicht:
509.56
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
